Though Landré-Beauvais classification of rheumatoid arthritis as a relative of gout was inaccurate, his dissertation encouraged others to further study the disease. Terminology
The term is derived from arthr- (from Ancient Greek: ἄρθρον, romanized: árthron, lit. joint) and -itis (from -ῖτις, -îtis, lit. pertaining to), the latter suffix having come to be associated with inflammation. The word arthritides is the plural form of arthritis, and denotes the collective group of arthritis-like conditions. See also
Antiarthritics
Arthritis Care (charity in the UK)
Arthritis Foundation (US not-for-profit)
Knee arthritis
Osteoimmunology
Weather pains

References
External links
Arthritis at Curlie
American College of Rheumatology – US professional society of rheumatologists
National Institute of Arthritis and Musculoskeletal and Skin Diseases - US National Institute of Arthritis and Musculoskeletal and Skin Diseases
Hyperprolactinaemia is the presence of abnormally high levels of prolactin in the blood. Normal levels average to about 13 ng/mL in women, and 5 ng/mL in men, with an upper normal limit of serum prolactin levels being 15-25 ng/mL for both. When the fasting levels of prolactin in blood exceed this upper limit,  hyperprolactinemia is indicated. Prolactin (PRL) is a peptide hormone produced by lactotroph cells in the anterior pituitary gland. PRL is involved in lactation after pregnancy and plays a vital role in breast development. Hyperprolactinemia may cause galactorrhea (production and spontaneous flow of breast milk), infertility, and disruptions in the normal menstrual period in women; as well as hypogonadism, infertility and erectile dysfunction in men. Although hyperprolactinemia can result from normal physiological changes during pregnancy and breastfeeding, it can also be caused by other etiologies. For example, high prolactin levels could result from diseases affecting the hypothalamus and pituitary gland. Other organs, such as the liver and kidneys, could affect prolactin clearance and consequently, prolactin levels in the serum. The disruption of prolactin regulation could also be attributed to external sources such as medications.In the general population, the prevalence of hyperprolactinemia is 0.4%. The prevalence increases to as high as 17% in women with reproductive diseases, such as polycystic ovary syndrome. In cases of tumor-related hyperprolactinemia, prolactinoma is the most common culprit of consistently high levels of prolactin as well as the most common type of pituitary tumor. For non-tumor related hyperprolactinemia, the most common cause is medication-induced prolactin secretion.